ENTITY
Kolon Life Science

Kolon Life Science (102940 KS)

14
Analysis
Health CareSouth Korea
Kolon Life Science., Inc. develops, manufactures, and sells Pharmaceutical Ingredients, Specialty Chemicals, Biotechnology, and Biological New Drugs. The Company's main products are anti-inflammatory drugs, drugs for the circulatory system, digestive & urinary system, antibiotics, etc.
more
07 Nov 2017 02:29

TissueGene IPO Part 5 - Recap on First Day Trade

TissueGene Inc. (950160 KS)'s opening price was set at ₩52,000. Well, this is a whopping 92.6% up from the IPO price of ₩27,000. Eventually, it...

Logo
264 Views
Share
17 Oct 2017 13:38

TissueGene IPO Part 3 - More Fact Gathering from Yesterday's Press Meeting

It is time to decide on TissueGene Inc. (950160 KS) IPO. Its bookbuilding is actually taking place today and tomorrow. I know this is a very...

Logo
320 Views
Share
02 Oct 2017 16:28

TissueGene IPO Part 2 - Facts About Cartilage Regeneration & US Clinical Trial

TissueGene Inc. (950160 KS) is 'still' clearly saying that its Invossa (TG-C) has the following three significant features. Requires only a single...

Logo
446 Views
Share
21 Sep 2017 19:58

TissueGene IPO Part 1 - IPO Prospectus Summary

What is Korea's hottest stock now? I guess many investors will have SillaJen, Inc. (0908477D KS) in their mind when asked this question. SillaJen's...

Logo
654 Views
Share
08 Dec 2016 08:24

MediSetter Interview: Insight on Opportunities in Asia's Healthcare Industry

Introduction to MedisetterI had the pleasure of interviewing Anirban Lahiri of Medisetter to discuss some of the opportunities present in Asia's...

Share
x